Description
| Product Name | CAT.No | Size |
| HbsAg / HCV / HIV/ Syphilis Combi | IDCOMB20 | 20T |
Product Description
The Biorex Diagnostics HIV/HCV/HBsAg/Syphilis Combo Rapid Test is a rapid immunochromatographic assay for the qualitative detection of HIV-1/2 antibodies, HCV antibodies, HBsAg, and Treponema pallidum antibodies in human serum or plasma. This multi-target screening tool enables fast and reliable preliminary assessment of four major infectious diseases within a single test device, offering a practical solution for healthcare professionals seeking efficient, accurate, and cost-effective screening capabilities. By consolidating multiple assays into one workflow, the Combo Rapid Test reduces testing time, minimises sample handling, and supports early clinical decision-making in a variety of settings.
Key Features
- Multi-disease detection – screens for HIV, HCV, HBV, and Syphilis in a single device
- Rapid results – qualitative outcomes within minutes for timely triage and evaluation
- High sensitivity and specificity – reliable preliminary identification of infections
- Instrument-free operation – ideal for point-of-care, clinics, hospitals, and field use
- Ready-to-use format – minimal preparation, simple visual interpretation, and flexible deployment
Benefits
Use of the Combo Rapid Test allows clinicians, screening officers, and public health providers to perform comprehensive infectious disease screening without the need for complex instrumentation or multiple test formats. Routine implementation helps support blood donor screening programmes, antenatal care pathways, substance misuse services, sexual health clinics, and community-based health initiatives where timely results can help inform next steps in patient assessment or management. The ability to detect HIV, HCV, HBV, and Syphilis markers simultaneously increases operational efficiency and improves testing throughput while reducing overall cost per screening episode.
The test’s rapid workflow enhances clinical responsiveness, enabling earlier recognition of infectious risks and more effective allocation of healthcare resources. In outreach settings or resource-limited environments, the instrument-free design allows screening to take place where laboratory infrastructure may be limited or unavailable. The clear and easy-to-interpret results also support preliminary decision-making and referral processes, particularly in preventive healthcare and epidemiological surveillance programmes.
Overall, the Biorex Diagnostics HIV/HCV/HBsAg/Syphilis Combo Rapid Test delivers a practical and clinically relevant solution for comprehensive infectious disease screening, offering speed, reliability, operational convenience, and expanded diagnostic coverage in a single device. It is a versatile tool that supports public health initiatives, patient safety, and improved testing efficiency across diverse healthcare environments.
Contact Us for more information.